Attached files
file | filename |
---|---|
EX-16.1 - LETTER DATED JANUARY 6, 2010, FROM GOLDSTEIN LEWIN & CO. TO THE SECURITIES AND EXCHANGE COMMISSION - Adamis Pharmaceuticals Corp | ex-16_1.htm |
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
Amendment
No. 1 to
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event
reported): January
1, 2010
ADAMIS PHARMACEUTICALS
CORPORATION
|
||
(Exact
name of registrant as specified in its charter)
|
Delaware
|
||
(State
or Other Jurisdiction of Incorporation)
|
82-0429727
|
||
(Commission
File Number: 0-26372)
|
(IRS
Employer Identification Number)
|
2658 Del Mar Heights Rd, #555, Del Mar, CA
92014
|
||
(Address
of executive offices and Zip Code)
|
(858)
401-3984
|
(Registrant's
Telephone Number, Including Area
Code)
|
(Former
name or former address, if changed since last report)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Explanatory
Note
This
amendment to Report on Form 8-K amends the original report on Form 8-K filed by
the registrant on January 7, 2010, and is being filed to correct the date on the
letter attached as exhibit 16.1 to the original Form 8-K, from January 6, 2009
to January 6, 2010.
Item
9.01 Financial
Statements and Exhibits
(d)
|
Exhibits:
|
||
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
ADAMIS
PHARMACEUTICALS, INC.
|
||||||
Dated:
|
January
11, 2010
|
By:
|
/s/ Robert O. Hopkins
|
|||
Name:
|
Robert
O. Hopkins
|
|||||
Title:
|
Chief
Financial Officer
|